Posted in | News | Business

First Patent Approval for Applied Graphene Materials

Applied Graphene Materials, the producer of specialty graphene materials, is pleased to report that it has received patent approval from the Japanese Patent Office in respect of its graphene production process.

The patent covers the proprietary process used by the Group for manufacturing graphene nanoplatelets.

This approval is the first of the Group's patent applications to be granted. Applications relating to the production process have been made in a total of five other geographic territories and these remaining applications continue to be pursued.

Jon Mabbitt, Chief Executive Officer, commented:

"The granting of this first patent for Applied Graphene Materials' graphene production process confirms the proprietary nature of our process. We anticipate that Japan will be an important market for the Group.

We are continuing to build on our existing platform of intellectual property and know how, concerning both the production of graphene and formatting graphene dispersions, to provide the greatest enhancements and performance benefits for our partners and customers."


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Applied Graphene Materials. (2019, March 18). First Patent Approval for Applied Graphene Materials. AZoM. Retrieved on June 15, 2024 from

  • MLA

    Applied Graphene Materials. "First Patent Approval for Applied Graphene Materials". AZoM. 15 June 2024. <>.

  • Chicago

    Applied Graphene Materials. "First Patent Approval for Applied Graphene Materials". AZoM. (accessed June 15, 2024).

  • Harvard

    Applied Graphene Materials. 2019. First Patent Approval for Applied Graphene Materials. AZoM, viewed 15 June 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.